Free Shipping on All Orders $75 Or More!

Your Trusted Brand for Over 35 Years

Health Protocols

Heart Failure


Aaronson, A. J., Morrissey, R. P., Nguyen, C. T., Willix, R., and Schwarz, E. R. Update on the safety of testosterone therapy in cardiac disease. Expert Opin Drug Saf. 2011;10(5):697–704

Abdel-Qadir, H. M., Lee, D.S. The contribution of familial and heritable risks in heart failure. Curr Opin Cardiol. 2007;22(3):214-9.

Adler ED, Goldfinger JZ, Kalman J, Park ME, Meier DE. Palliative Care in the Treatment of Advanced Heart Failure. Circulation. 2009;120(25):2597-2606.

AHA. American Heart Association. Conditions: Advanced Heart Failure. Last updated 5/9/2017a. Accessed 11/3/2017.

AHA. American Heart Association. How do beta blocker drugs affect exercise? Copyright 2017b. Accessed 11/3/2017.

Albert, N.M., Fonarow, G.C., Abraham, W.T., Gheorghiade, M., Greenberg, B.H., Nunez, E., et al. Depression and clinical outcomes in heart failure: an OPTIMIZE-HF analysis. Am J Med. 2009;122(4):366-73

Almoznino-Sarafian D, Sarafian G, Berman S, Shteinshnaider M, Tzur I, Cohen N, Gorelik O. Magnesium administration may improve heart rate variability in patients with heart failure. Nutrition, metabolism, and cardiovascular diseases : NMCD. Nov 2009;19(9):641-645.

Alshammari TM. Ivabradine: Do the Benefits Outweigh the Risks? Journal of cardiovascular pharmacology and therapeutics. May 2017;22(3):210-218.

American Heart Association. Ejection Fraction Heart Failure Measurement. 2012; Available at: [Accessed April 3, 2013].

Amin, A., Minaee, S., Chitsazan, M., Naderi, N., Taghavi, S., and Ardeshiri, M. Can Vitamin D Supplementation Improve the Severity of Congestive Heart Failure? Congest Heart Fail. 2013; Mar 21. doi: 10.1111/chf.12026. [Epub ahead of print].

AMR. Terminalia arjuna. Alternative medicine review : a journal of clinical therapeutic. Dec 1999;4(6):436-437.

Anand, I., Chandrashekhan, Y., De Giuli, F.,  Acute and chronic effects of propionyl-L-carnitine on the hemodynamics, exercise capacity, and hormones in patients with congestive heart failure. Cardiovasc Drugs Ther. 1998;12(3):291–9

Ansley, D. M., and Wang, B. Oxidative stress and myocardial injury in the diabetic heart. J. Pathol. 2013;229(2):232–41

Aronsohn RS, Whitmore H et al. Impact of Untreated Obstructive Sleep Apnea on Glucose control in Type 2 Diabetes. American Journal of Respiratory Critical Care, 2010; 181; 507-513

Assmus B, Rolf A, Erbs S, et al. Clinical outcome 2 years after intracoronary administration of bone marrow-derived progenitor cells in acute myocardial infarction. Circulation. Heart failure.Jan 2010;3(1):89-96.

Aukrust, P., Ueland, T., Gullestad, L., and Yndestad, A. Testosterone: a novel therapeutic approach in chronic heart failure? J Am Coll Cardiol. 2009;54(10):928–9

Avni T, Leibovici L, Gafter-Gvili A. Iron supplementation for the treatment of chronic heart failure and iron deficiency: systematic review and meta-analysis. European journal of heart failure. Apr 2012;14(4):423-429.

Azizi-Namini, P., Ahmed, M., Yan, A. T., and Keith, M. The role of B vitamins in the management of heart failure. Nutr Clin Pract. 2012;27(3):363–74

Azuma, J., Sawamura, A., and Awata, N. Usefulness of taurine in chronic congestive heart failure and its prospective application. Jpn. Circ. J. 1992;56(1):95–9

Bae, S., Singh, S. S., Yu, H., Lee, J. Y., Cho, B. R., and Kang, P. M. Vitamin D signaling pathway plays an important role in the development of heart failure after myocardial infarction. J Appl Physiol. 2013;114(8):979–87

Baxalta US Inc. A Prospective, Randomized, Double-blind, Active-control and Unblinded Standard of Care (SOC) Controlled Study to Determine the Efficacy and Safety of Targeted Intramyocardial Delivery of Autologous CD34+ Cells (Auto-CD34+ Cells) for Increasing Exercise Capacity During Standardized Exercise Testing in Subjects With Refractory Angina Pectoris and Chronic Myocardial Ischemia. In: [Internet]. Bethesda (MD): National Library of Medicine (US). Last updated 2015 Dec 11. Available from NLM Identifier: NCT01508910.

Beveridge, L. A., and Witham, M. D. Vitamin D and the cardiovascular system. Osteoporos Int. 2013; 24(8):167-80.

Beyranvand, M. R., Khalafi, M. K., Roshan, V. D., Choobineh, S., Parsa, S. A., and Piranfar, M. A. Effect of taurine supplementation on exercise capacity of patients with heart failure. J Cardiol. 2011;57(3):333–7

Bharani A, Ahirwar LK, Jain N. Terminalia arjuna reverses impaired endothelial function in chronic smokers. Indian heart journal. Mar-Apr 2004;56(2):123-128.

BHS. Britis Hypertension Society. Drug Classes: Angiotensin Converting Enzyme (ACE) Inhibitors. 12/2008. Accessed 11/3/2017.

Bibevski, S., Dunlap, M.E. Evidence for impaired vagus nerve activity in heart failure. Heart Fail Rev. 2011;16(2):129-35

Booth RE, Johnson JP, Stockand JD. Aldosterone. Advances in physiology education. Dec 2002;26(1-4):8-20.

Britton, K.A., Gaziano, J.M., Djoussé, L. Normal systolic blood pressure and risk of heart failure in US male physicians. Eur J Heart Fail. 2009;11(12):1129-34

Brodbin P, O'Connor CA. Trimetazidine in the treatment of angina pectoris. The British journal of clinical practice. Sep 1968;22(9):395-396.

Brozena, S. C., and Jessup, M. The new staging system for heart failure. What every primary care physician should know. Geriatrics. 2003;58(6):31–6–quiz38

Brum PC, Bacurau AV, Medeiros A, Ferreira JC, Vanzelli AS, Negrao CE. Aerobic exercise training in heart failure: impact on sympathetic hyperactivity and cardiac and skeletal muscle function. Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas / Sociedade Brasileira de Biofisica ... [et al.]. Sep 2011;44(9):827-835.

Bryson, C. L., Mukamal, K. J., Mittleman, M. A.,  The Association of Alcohol Consumption and Incident Heart Failure. J Am Coll Cardiol. 2006;48(2):305–11

CDC (Centers for Disease Control and Prevention) (US); National Center for Chronic Disease Prevention and Health Promotion (US); Office on Smoking and Health (US). How Tobacco Smoke Causes Disease: The Biology and Behavioral Basis for Smoking-Attributable Disease: A Report of the Surgeon General. Atlanta (GA): Centers for Disease Control and Prevention (US); 2010. 6, Cardiovascular Diseases. Available from:

Ceremuzyński, L., Gebalska, J., Wolk, R., and Makowska, E. Hypomagnesemia in heart failure with ventricular arrhythmias. Beneficial effects of magnesium supplementation. Acta Med Scand. 2000;247(1):78–86

Ceylad. Efficacy and Safety of Bone Marrow-derived Mesenchymal Cardiopoietic Cells (C3BS-CQR-1) for the Treatment of Chronic Advanced Ischemic Heart Failure. In: [Internet]. Bethesda (MD): National Library of Medicine (US). Last updated 2015 May 18. Available from NLM Identifier: NCT01768702.

Clair, C., Rigotti, N.A., Porneala, B., Fox, C.S., D'Agostino, R.B., Pencina, M.J., Meigs, J.B. Association of smoking cessation and weight change with cardiovascular disease among adults with and without diabetes. JAMA. 2013;309(10):1014-21

Comella K, Parcero J, Bansal H, Perez J, Lopez J, Agrawal A, Ichim T. Effects of the intramyocardial implantation of stromal vascular fraction in patients with chronic ischemic cardiomyopathy. J Transl Med.2016;14(1):158.

Comin-Colet J, Enjuanes C, Gonzalez G, Torrens A, Cladellas M, Merono O, . . . Bruguera J. Iron deficiency is a key determinant of health-related quality of life in patients with chronic heart failure regardless of anaemia status. European journal of heart failure. Jul 15 2013.

Conard, M.W., Haddock, C.K., Poston, W.S., Spertus, J.A., and the Cardiovascular Outcomes Research Consortium. The impact of smoking status on the health status of heart failure patients. Congest Heart Fail. 2009;15(2):82-6

Cutler, D.J., Isner, J.M., Bracey, A.W., Hufnagel, C.A., Conrad, P.W., Roberts, W.C., et al. Hemochromatosis heart disease: an unemphasized cause of potentially reversible restrictive cardiomyopathy. Am J Med. 1980;69(6):923-8

Davis K, Dietrich E. Ivabradine (Corlanor) for Heart Failure. American family physician. Apr 15 2016;93(8):682-684.

De Ferrari, G. M., Crijns, H. J. G. M., Borggrefe, M.,  Chronic vagus nerve stimulation: a new and promising therapeutic approach for chronic heart failure. European Heart Journal. 2011;32(7):847–55

de Miguel Diez J, Morgan JC, Garcia RJ. The association between COPD and heart failure risk: a review. International journal of chronic obstructive pulmonary disease. 2013;8:305-312.

Di Angelantonio, E., Chowdhury, R., Sarwar, N.,  B-type natriuretic peptides and cardiovascular risk: systematic review and meta-analysis of 40 prospective studies. Circulation. 2009;120(22):2177–87

Djousse L, Gaziano JM. Alcohol consumption and heart failure: a systematic review. Current atherosclerosis reports. Apr 2008;10(2):117-120.

Downing, J., and Balady, G. J. The role of exercise training in heart failure. J Am Coll Cardiol. 2011;58(6):561–9

Drager LF, Polotsky VY, et al. Obstructive Sleep Apnea: An Emerging Risk Factor for Atherosclerosis. Chest. 2011;140:534-42.

Dubrey, S.W., Bell, A., Mittal, T.K. Sarcoid heart disease. Postgrad Med J. 2007;83(984):618-23

Dunn, S. P., Bleske, B., Dorsch, M., Macaulay, T., Van Tassell, B., and Vardeny, O. Nutrition and heart failure: impact of drug therapies and management strategies. Nutrition in Clinical Practice. 2009;24(1):60–75

Dwivedi S. Terminalia arjuna Wight & Arn.--a useful drug for cardiovascular disorders. Journal of ethnopharmacology. Nov 1 2007;114(2):114-129.

Ehle M, Patel C, Giugliano RP. Digoxin: clinical highlights: a review of digoxin and its use in contemporary medicine. Critical pathways in cardiology. Jun 2011;10(2):93-98.

Falk, R.H., Dubrey, S.W. Amyloid heart disease. Prog Cardiovasc Dis. 2010;52(4):347-61

Faloon W. Life Extension Magazine. How to Circumvent 17 Independent Heart Attack Risk Factors. May. 2009.

Farroni, J.A. Pheochromocytoma presenting as heart failure. Prog Cardiovasc Nurs. 2005;20(3):117-9

Ferri FF. Ferri's Clinical Advisor. Heart Failure. Available at: Accessed 8/8/2013. 2013.

Filippatos G, Farmakis D, Colet JC, Dickstein K, Luscher TF, Willenheimer R, . . . Anker SD. Intravenous ferric carboxymaltose in iron-deficient chronic heart failure patients with and without anaemia: a subanalysis of the FAIR-HF trial. European journal of heart failure. Jul 18 2013.

Fish KM, Hajjar RJ. Mesenchymal Stem Cells & Endothelial Function. EBioMedicine.May 2015;2(5):376-377.

Fisker FY, Grimm D, Wehland M. Third-generation beta-adrenoceptor antagonists in the treatment of hypertension and heart failure. Basic Clin Pharmacol Toxicol. Jul 2015;117(1):5-14.

Foley PM. Clinical Key. First Consult; Heart Failure. Available at: Accessed 7/19/2013. 2012.

Folkers K, Langsjoen P, Willis R, Richardson P, Xia LJ, Ye CQ, Tamagawa H. Lovastatin decreases coenzyme Q levels in humans. Proceedings of the National Academy of Sciences of the United States of America. Nov 1990;87(22):8931-8934.

Fonarow, G. C., Stough, W. G., Abraham, W. T., et al. Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry. J Am Coll Cardiol. 2007;50(8):768–77

Fotino, A. D., Thompson-Paul, A. M., and Bazzano, L. A. Effect of coenzyme Q₁₀ supplementation on heart failure: a meta-analysis. American Journal of Clinical Nutrition. 2013;97(2):268–75

Fuentes JC, Salmon AA, Silver MA. Acute and chronic oral magnesium supplementation: effects on endothelial function, exercise capacity, and quality of life in patients with symptomatic heart failure. Congestive heart failure (Greenwich, Conn.). Jan-Feb 2006;12(1):9-13.

Furey, A., and Tassell, M. Towards a systematic scientific approach in the assessment of efficacy of an herbal preparation: Hawthorn (Crataegus spp.). European Journal of Heart Failure. 2008;10(12):1153–7.

Gao D, Ning N, Niu X, Hao G, Meng Z. Trimetazidine: a meta-analysis of randomised controlled trials in heart failure. Heart (British Cardiac Society). Feb 2011;97(4):278-286.

Garbern JC, Lee RT. Cardiac Stem Cell Therapy and the Promise of Heart Regeneration. Cell stem cell.2013;12(6):689-698.

Gauthaman K, Maulik M, Kumari R, Manchanda SC, Dinda AK, Maulik SK. Effect of chronic treatment with bark of Terminalia arjuna: a study on the isolated ischemic-reperfused rat heart. Journal of ethnopharmacology. May 2001;75(2-3):197-201.

Geleijnse, J. M., Giltay, E. J., Grobbee, D. E., Donders, A. R. T., and Kok, F. J. Blood pressure response to fish oil supplementation: metaregression analysis of randomized trials. J. Hypertens. 2002;20(8):1493–9

Gerbin KA, Murry CE. The winding road to regenerating the human heart. Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.2015;24(3):133-140.

Giagulli VA, Guastamacchia E, De Pergola G, Iacoviello M, Triggiani V. Testosterone Deficiency in Male: A Risk Factor for Heart Failure. Endocrine, metabolic & immune disorders drug targets. Jan 15 2013.

Glickman-Simon, R., and Ehrlich, A. Leeches, creatine, xylitol, spinal manipulation, acupuncture. Explore (NY). 2012;8(3):206–9

Goldman, L. Schafer, A.L. Goldman's Cecil Medicine , Twenty-Fourth Edition. Heart Failure. Pathophysiology and Diagnosis. Available at: Accessed 7/10/2013.

Gottlieb, D.J., Yenokyan, G., Newman, A.B., O'Connor, G.T., Punjabi, N.M., Quan, S.F., et al. Prospective study of obstructive sleep apnea and incident coronary heart disease and heart failure: the sleep heart health study. Circulation. 2010;122(4):352-60

Gujja P, Rosing DR, Tripodi DJ, Shizukuda Y. Iron overload cardiomyopathy: better understanding of an increasing disorder. Journal of the American College of Cardiology. Sep 21 2010;56(13):1001-1012.

Gupta R, Singhal S, Goyle A, Sharma VN. Antioxidant and hypocholesterolaemic effects of Terminalia arjuna tree-bark powder: a randomised placebo-controlled trial. The Journal of the Association of Physicians of India. Feb 2001;49:231-235.

Hamilton DJ. Mechanisms of disease: is mitochondrial function altered in heart failure? Methodist DeBakey cardiovascular journal. Jan-Mar 2013;9(1):44-48.

Harinstein, M. E., Filippatos, G. S., and Gheorghiade, M. Acute heart failure syndromes: epidemiology, risk stratification and prognostic factors. Acute Card Care. 2009;11(2):77–82

He J, Ogden LG, Bazzano LA, Vupputuri S, Loria C, Whelton PK. Risk factors for congestive heart failure in US men and women: NHANES I epidemiologic follow-up study. Archives of internal medicine. Apr 9 2001;161(7):996-1002.

He, F. J., Burnier, M., and Macgregor, G. A. Nutrition in cardiovascular disease: salt in hypertension and heart failure. European Heart Journal. 2011;32(24):3073–80

He, J., Ogden, L. G., Bazzano, L. A., Vupputuri, S., Loria, C., and Whelton, P. K. Dietary sodium intake and incidence of congestive heart failure in overweight US men and women: first National Health and Nutrition Examination Survey Epidemiologic Follow-up Study. Arch Intern Med. 2002;162(14):1619–24

Heidenreich, P. A., Albert, N. M., Allen, L. A., et al. Forecasting the Impact of Heart Failure in the United States: A Policy Statement From the American Heart Association. Circ Heart Fail. 2013; 6(3):606-19.

Heist, E. K., and Ruskin, J. N. Atrial fibrillation and congestive heart failure: risk factors, mechanisms, and treatment. Prog Cardiovasc Dis. 2006;48(4):256–69

Hoeper, M.M. Pulmonary hypertension in collagen vascular disease. Eur Respir J. 2002;19(3):571-6

Holubarsch CJF, Colucci WS, Meinertz T, et al. Survival and Pronosis: Investigation of Crataegus Extract WS 1442 in congestive heart failure (SPICE) – rationale, study design and study protocol. European Journal of Heart Failure 2. 2000;431-37.

Holubarsch, C. J. F., Colucci, W. S., Meinertz, T., Gaus, W., Tendera, M., Survival and Prognosis: Investigation of Crataegus Extract WS 1442 in CHF (SPICE) trial study group. The efficacy and safety of Crataegus extract WS 1442 in patients with heart failure: the SPICE trial. Eur. J. Heart Fail. 2008;10(12):1255–63

Hori, M. Tolvaptan for heart failure patients with volume overload. Cardiovasc Drug Ther. 2011;25 Suppl 1:S1–4

Horjus, D. L., Oudman, I., van Montfrans, G. A., and Brewster, L. M. Creatine and creatine analogues in hypertension and cardiovascular disease. Cochrane Database Syst Rev. 2011;(11):CD005184

Hunt, S. A., Abraham, W. T., Chin, M. H., 2009 Focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation. J Am Coll Cardiol. 2009;53(15):e1–e90

Hunt, S. A., Abraham, W. T., Chin, M. H., ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation. 2005;112(12):e154–235

Iellamo, F., Volterrani, M., Caminiti, G., et al. Testosterone therapy in women with chronic heart failure: a pilot double-blind, randomized, placebo-controlled study. J Am Coll Cardiol. 2010;56(16):1310–6

Ingwall JS. Energy metabolism in heart failure and remodelling. Cardiovascular research. Feb 15 2009;81(3):412-419.

Iwanaga Y, Miyazaki S. Heart failure, chronic kidney disease, and biomarkers--an integrated viewpoint. Circulation journal : official journal of the Japanese Circulation Society. Jul 2010;74(7):1274-1282.

Izzo JL, Jr., Weir MR. Angiotensin-converting enzyme inhibitors. Journal of clinical hypertension (Greenwich, Conn.). Sep 2011;13(9):667-675.

Jankowska EA, Rozentryt P, Witkowska A, Nowak J, Hartmann O, Ponikowska B, . . . Ponikowski P. Iron deficiency: an ominous sign in patients with systolic chronic heart failure. European heart journal. Aug 2010;31(15):1872-1880.

Jankowska, E. A., Biel, B., Majda, J., et al. Anabolic deficiency in men with chronic heart failure: prevalence and detrimental impact on survival. Circulation. 2006;114(17):1829–37

Jankowska, E. A., Filippatos, G., Ponikowska, B., et al. Reduction in circulating testosterone relates to exercise capacity in men with chronic heart failure. J. Card. Fail. 2009;15(5):442–50

Jessup, M., Abraham, W. T., Casey, D. E.,  2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation. 2009;119(14):1977–2016

Jessup, M., and Brozena, S. Heart failure. N Engl J Med. 2003;348(20):2007–18

Kalicinska E, Wojtas K, Majda J, Doehner W, Haehling SV, Banasiak W, . . . Jankowska EA. Anabolic deficiencies in men with systolic heart failure: do co-morbidities and therapies really contribute significantly? The aging male : the official journal of the International Society for the Study of the Aging Male. Jun 26 2013.

Kanamori, H., Takemura, G., Goto, K., Tsujimoto, A., Ogino, A., Takeyama, T., et al. Resveratrol reverses remodeling in hearts with large, old myocardial infarctions through enhanced autophagy-activating AMP kinase pathway. Am J Pathol. 2013;182(3):701-13

Kannel, W.B. Incidence and epidemiology of heart failure. Heart Fail Rev. 2000;5(2):167-73

Kapitanyan R, Su M. Drugs & Diseases page. Cardiac Glycoside Plant Poisoning: Practice Essentials. Last updated 3/28/2017. Accessed 11/3/2017.

Kaplinsky E. Changing the treatment of heart failure with reduced ejection fraction: clinical use of sacubitril-valsartan combination. Journal of geriatric cardiology : JGC. Nov 2016;13(11):914-923.

Kapoor M, Schleinitz MD, Gemignani A, Wu WC. Outcomes of patients with chronic heart failure and iron deficiency treated with intravenous iron: a meta-analysis. Cardiovascular & hematological disorders drug targets. Mar 1 2013;13(1):35-44.

Karppi J, Kurl S, Makikallio TH, Ronkainen K, Laukkanen JA. Serum beta-carotene concentrations and the risk of congestive heart failure in men: A population-based study. International journal of cardiology. Jan 17 2013.

Karthikeyan K, Bai BR, Gauthaman K, Sathish KS, Devaraj SN. Cardioprotective effect of the alcoholic extract of Terminalia arjuna bark in an in vivo model of myocardial ischemic reperfusion injury. Life sciences. Oct 10 2003;73(21):2727-2739.

Kasai T. Sleep apnea and heart failure. Journal of cardiology. Aug 2012;60(2):78-85.

Kenchaiah, S., Narula, J., and Vasan, R. S. Risk factors for heart failure. Med. Clin. North Am. 2004;88(5):1145–72

Khanabdali R, Rosdah AA, Dusting GJ, Lim SY. Harnessing the secretome of cardiac stem cells as therapy for ischemic heart disease. Biochemical pharmacology.Aug 1 2016;113:1-11.

Kilicgedik A, Dundar C, Tigen MK. Anemia in heart failure. Anadolu kardiyoloji dergisi : AKD = the Anatolian journal of cardiology. Feb 2012;12(1):65-70.

King JB, Shah RU, Bress AP, Nelson RE, Bellows BK. Cost-Effectiveness of Sacubitril-Valsartan Combination Therapy Compared With Enalapril for the Treatment of Heart Failure With Reduced Ejection Fraction. JACC. Heart failure. May 2016;4(5):392-402.

Klip IT, Comin-Colet J, Voors AA, Ponikowski P, Enjuanes C, Banasiak W, . . . Jankowska EA. Iron deficiency in chronic heart failure: an international pooled analysis. American heart journal. Apr 2013;165(4):575-582.e573.

Koch, E., and Malek, F. A. Standardized extracts from hawthorn leaves and flowers in the treatment of cardiovascular disorders--preclinical and clinical studies. Planta Med. 2011;77(11):1123–8

Kotwal, S., Jun, M., Sullivan, D., Perkovic, V., and Neal, B. Omega 3 Fatty acids and cardiovascular outcomes: systematic review and meta-analysis. Circ Cardiovasc Qual Outcomes. 2012;5(6):808–18

Kremastinos DT, Farmakis D. Iron overload cardiomyopathy in clinical practice. Circulation. Nov 15 2011;124(20):2253-2263.

Krim, S. R., Campbell, P., Lavie, C. J., and Ventura, H. Micronutrients in chronic heart failure. Curr Heart Fail Rep. 2013;10(1):46–53

Kwak, S. M., Myung, S.-K., Lee, Y. J., Seo, H. G., Korean Meta-analysis Study Group. Efficacy of omega-3 fatty acid supplements (eicosapentaenoic acid and docosahexaenoic acid) in the secondary prevention of cardiovascular disease: a meta-analysis of randomized, double-blind, placebo-controlled trials. Arch Intern Med. 2012;172(9):686–94

Langsjoen P, Littarru G, Silver M. Potential role of concomitant coenzyme Q~ 1~ 0 with statins for patients with hyperlipidemia. Current Topics in Nutraceutical Research. 2005;3(3):149.

Langsjoen PH, Langsjoen JO, Langsjoen AM, Lucas LA. Treatment of statin adverse effects with supplemental Coenzyme Q10 and statin drug discontinuation. BioFactors. 2005;25(1-4):147-152.

Liu, L. C. Y., Voors, A. A., van Veldhuisen, D. J., et al. Vitamin D status and outcomes in heart failure patients. Eur. J. Heart Fail. 2011;13(6):619–25

Lopaschuk GD, Ussher JR, Folmes CD, Jaswal JS, Stanley WC. Myocardial fatty acid metabolism in health and disease. Physiological reviews. Jan 2010;90(1):207-258.

Lymbury, R.S., Marino, M.J., Perkins, A.V. Effect of dietary selenium on the progression of heart failure in the ageing spontaneously hypertensive rat. Mol Nutr Food Res. 2010;54(10):1436-44

Maisel AS, Krishnaswamy P, Nowak RM, McCord J, Hollander JE, Duc P, . . . McCullough PA. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. The New England journal of medicine. Jul 18 2002;347(3):161-167.

Malkin CJ, Channer KS, Jones TH. Testosterone and heart failure. Current Opinion in Endocrinology, Diabetes & Obesity. 2010;17:262-68.

Malkin CJ, Pugh PJ, West JN, et al. Testosterone therapy in men with moderate severity heart failure: a double-blind randomized placebo controlled trial. European Heart Journal. 2006;27:57-64.

Mancini, M., Rengo, F., Lingetti, M., Sorrentino, G. P., and Nolfe, G. Controlled study on the therapeutic efficacy of propionyl-L-carnitine in patients with congestive heart failure. Arzneimittelforschung. 1992;42(9):1101–4

Mangalat, D., Kalogeropoulos, A., Georgiopoulou, V., Stillman, A., Butler, J. Value of Cardiac CT in Patients With Heart Failure. Curr Cardiovasc Imaging Rep. 2009;2(6):410-417

Marieb, E., and Hoehn, K. Human anatomy & physiology. 8 ed. San Francisco: Pearson Benjamin Cummings. 2010.

Marik, P. E., and Varon, J. Omega-3 dietary supplements and the risk of cardiovascular events: a systematic review. Clin Cardiol. 2009;32(7):365–72

Marques da Silva P, Aguiar C. Sacubitril/valsartan: An important piece in the therapeutic puzzle of heart failure. Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology. Sep 2017;36(9):655-668.

Marthur A; Queen Mary University of London. The Effect of Intracoronary Reinfusion of Bone Marrow-derived Mononuclear Cells (BM-MNC) on All Cause Mortality in Acute Myocardial Infarction. In: [Internet]. Bethesda (MD): National Library of Medicine (US). Last updated 2016 June 10. Available from NLM Identifier: NCT01569178.

Masmoudi K, Masson H, Gras V, Andrejak M. Extrapyramidal adverse drug reactions associated with trimetazidine: a series of 21 cases. Fundamental & clinical pharmacology. Apr 2012;26(2):198-203.

Maulik SK, Katiyar CK. Terminalia arjuna in cardiovascular diseases: making the transition from traditional to modern medicine in India. Current pharmaceutical biotechnology. Dec 2010;11(8):855-860.

Mayo Clinic. Diseases and Conditions: High blood pressure (hypertension). 9/9/2016. Accessed 11/3/2017.

Mayo Clinic. High blood pressure (hyperension). 2011. Available at: Last updated 6/7/2011. Accessed 7/24/2013.

McKeag, N.A., McKinley, M.C., Woodside, J.V., Harbinson, M.T., McKeown, P.P. The role of micronutrients in heart failure. J Acad Nutr Diet. 2012;112(6):870-86.

McKelvie, R. S., Moe, G. W., Ezekowitz, J. A.,  The 2012 Canadian Cardiovascular Society heart failure management guidelines update: focus on acute and chronic heart failure. Can J Cardiol. 2013;29(2):168–81

McMurray JJ, Pfeiffer MA. Goldman-Cecil Medicine, Twenty-Fifth Edition. Chapter 59: Heart Failure: Management and Prognosis; 305-320e1. Copyright 2016 by Saunders, an imprint of Elsevier, Inc. Accessed 11/3/2017.

McQueen, M. J., Kavsak, P. A., Xu, L., Shestakovska, O., and Yusuf, S. Predicting myocardial infarction and other serious cardiac outcomes using high-sensitivity cardiac troponin T in a high-risk stable population. Clin. Biochem. 2013;46(1-2):5–9

Mehra, M. R., Lavie, C. J., Ventura, H. O., and Milani, R. V. Fish oils produce anti-inflammatory effects and improve body weight in severe heart failure. J. Heart Lung Transplant. 2006;25(7):834–8

Michler RE. Stem cell therapy for heart failure. Cardiology in review.May-Jun 2014;22(3):105-116.

Molyneux SL, Florkowski CM, George PM, Pilbrow AP, Frampton CM, Lever M, Richards AM. Coenzyme Q10: an independent predictor of mortality in chronic heart failure. Journal of the American College of Cardiology. Oct 28 2008;52(18):1435-1441.

Montastruc JL, Sommet A, Olivier P, Bagheri H, Gony M, Lapeyre-Mestre M, . . . Rascol O. [Drugs, Parkinson's disease and parkinsonian syndroms: recent advances in pharmacovigilance]. Therapie. Jan-Feb 2006;61(1):29-38.

Mortensen S, Kumar A, Filipiak K, et al. The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure. Results from the Q-SYMBIO study. European Journal of Heart Failure. 2013;15(S1):S20.

Muller-Werdan U, Stockl G, Werdan K. Advances in the management of heart failure: the role of ivabradine. Vasc Health Risk Manag. 2016;12:453-470.

Murphy CJ, Oudit GY. Iron-overload cardiomyopathy: pathophysiology, diagnosis, and treatment. Journal of cardiac failure. Nov 2010;16(11):888-900.

N.Y. Criteria Committee, N. Y. H. A. Diseases of the Heart and Blood Vessels. Nomenclature and Criteria for Diagnosis ... Sixth Edition. [With Illustrations.]. 1964.

Nagarajan, V., and Tang, W. H. W. Biomarkers in advanced heart failure: diagnostic and therapeutic insights. Congest Heart Fail. 2011;17(4):169–74

Nagarajan, V., Hernandez, A. V., and Tang, W. H. W. Prognostic value of cardiac troponin in chronic stable heart failure: a systematic review. Heart. 2012;98(24):1778–86

NHLBI. What Is Heart Failure? - NHLBI, NIH. National Heart, Lung, and Blood Institute. 2012; Available at: [Accessed May 15, 2013].

Nieto FJ, Peppard PE, Young T, et al. Sleep disordered breathing and cancer mortality: results from the Wisconsin Sleep Cohort Study. Am J Respir Crit Care Med. 2012 May 20. [Epub ahead of print]

Nishio, Y., Sato, Y., Taniguchi, R., Shizuta, S., Doi, T., Morimoto, T., Kimura, T., Kita, T. Cardiac troponin T vs other biochemical markers in patients with congestive heart failure. Circ J. 2007;71(5):631-5

NLM. U. S. National Library of Medicine. Stem Cells. Last updated 9/16/2016. Accessed 9/29/2016.

Oberoi L, Akiyama T, Lee KH, Liu SJ. The aqueous extract, not organic extracts, of Terminalia arjuna bark exerts cardiotonic effect on adult ventricular myocytes. Phytomedicine : international journal of phytotherapy and phytopharmacology. Feb 15 2011;18(4):259-265.

O'Connell, J. B., and Alemayehu, A. Hyponatremia, heart failure, and the role of tolvaptan. Postgrad Med. 2012;124(2):29–39

Oerkild, B., Frederiksen, M., Hansen, J.F., Prescott, E. Self-reported physical inactivity predicts survival after hospitalization for heart disease. Eur J Cardiovasc Prev Rehabil. 2011;18(3):475-80

Omran H, Illien S, MacCarter D, et al. D-Ribose improves diastolic function and quality of life in congestive heart failure patients: a prospective feasibility study. The European Journal of Heart Failure (2003); 5: 615-19.

Omran, H., McCarter, D., St Cyr, J., and Lüderitz, B. D-ribose aids congestive heart failure patients. Exp Clin Cardiol. 2004;9(2):117–8

Orlic D, Kajstura J, Chimenti S, Bodine DM, Leri A, Anversa P. Transplanted adult bone marrow cells repair myocardial infarcts in mice. Annals of the New York Academy of Sciences. Jun 2001;938:221-229; discussion 229-230.

Page, J., and Henry, D. Consumption of NSAIDs and the Development of Congestive Heart Failure in Elderly PatientsAn Underrecognized Public Health Problem. Arch Intern Med. 2000;160(6):777–84

Papanas, N., Maltezos, E., and Mikhailidis, D. P. Metformin and heart failure: never say never again. Expert Opin Pharmacother. 2012;13(1):1–8

Pedrosa RP, Drager LF, Gonzaga CC, et al. Obstructive Sleep Apnea: The Most Common Secondary Cause of Hypertension Associated with Resistant Hypertension. Hypertension. 2011;58:811-17.

Pereira CA, Roscani MG, Zanati SG, Matsubara BB. Anemia, heart failure and evidence-based clinical management. Arquivos brasileiros de cardiologia. Jul 2013;101(1):87-92.

Piano MR. Alcoholic cardiomyopathy: incidence, clinical characteristics, and pathophysiology. Chest. May 2002;121(5):1638-1650.

Pollentier, B., Irons, S. L., Benedetto, C. M., Examination of the six minute walk test to determine functional capacity in people with chronic heart failure: a systematic review. Cardiopulm Phys Ther J. 2010;21(1):13–21

Pourdjabbar, A., Dwivedi, G., and Haddad, H. The role of vitamin D in chronic heart failure. Curr. Opin. Cardiol. 2013;28(2):216–22

Punjabi NM. The Epidemiology of Adult Obstructive Sleep Apnea. Proc Am Thorac Soc. 2008;5(2):136-43.

Ram A, Lauria P, Gupta R, Kumar P, Sharma VN. Hypocholesterolaemic effects of Terminalia arjuna tree bark. Journal of ethnopharmacology. Feb 1997;55(3):165-169.

Rathnayake D, Sinclair R. Use of spironolactone in dermatology. Skinmed. Nov-Dec 2010;8(6):328-332; quiz 333.

Rigelsky JM, Sweet BV. Hawthorn: pharmacology and therapeutic uses. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. Mar 1 2002;59(5):417-422.

Rizos, I. Three-year survival of patients with heart failure caused by dilated cardiomyopathy and L-carnitine administration. Am. Heart J. 2000; 139(2 Pt 3):S120-3.

Rosenfeldt, F. L., Haas, S. J., Krum, H.,  Coenzyme Q10 in the treatment of hypertension: a meta-analysis of the clinical trials. J Hum Hypertens. 2007;21(4):297–306

Rucker, R., Chowanadisai, W., and Nakano, M. Potential physiological importance of pyrroloquinoline quinone. Altern Med Rev. 2009;14(3):268–77

Sabbah, H.N. Electrical vagus nerve stimulation for the treatment of chronic heart failure. Cleve Clin J Med. 2011;78 Suppl 1:S24-9

Sacks, F., Svetkey, L., Vollmer, W., and Appel, L. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. N Engl J Med. 2001; 344(1):3-10.

Saliba, W., El Fakih, R., Shaheen, W. Heart failure secondary to selenium deficiency, reversible after supplementation. Int J Cardiol. 2010;141(2):e26-7

Sander, S., Coleman, C. I., Patel, A. A., Kluger, J., and White, C. M. The impact of coenzyme Q10 on systolic function in patients with chronic heart failure. J. Card. Fail. 2006;12(6):464–72

Schleithoff, S. S., Zittermann, A., Tenderich, G., Berthold, H. K., Stehle, P., and Koerfer, R. Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: a double-blind, randomized, placebo-controlled trial. Am J Clin Nutr. 2006;83(4):754–9

Schröder, D., Weiser, M., Klein, P. Efficacy of a homeopathic Crataegus preparation compared with usual therapy for mild (NYHA II) cardiac insufficiency: results of an observational cohort study. Eur J Heart Fail. 2003;5(3):319-26

Sehn E, McDonald T, Lindblad AJ. Sacubitril-valsartan: novel therapy for heart failure. Canadian family physician Medecin de famille canadien. Sep 2017;63(9):697.

Shah R, Agarwal AK. Anemia associated with chronic heart failure: current concepts. Clinical interventions in aging. 2013;8:111-122.

Shaila HP, Udupa SL, Udupa AL. Hypolipidemic activity of three indigenous drugs in experimentally induced atherosclerosis. International journal of cardiology. Dec 1 1998;67(2):119-124.

Shecterle, L. M., Wagner, S., and St Cyr, J. A. A sugar for congestive heart failure patients. Ther Adv Cardiovasc Dis. 2011;5(2):95–7

Shoemaker, M. J., Curtis, A. B., Vangsnes, E., and Dickinson, M. G. Triangulating Clinically Meaningful Change in the Six-minute Walk Test in Individuals with Chronic Heart Failure: A Systematic Review. Cardiopulm Phys Ther J. 2012;23(3):5–15

Silver MA, Langsjoen PH, Szabo S, Patil H, Zelinger A. Effect of atorvastatin on left ventricular diastolic function and ability of coenzyme Q10 to reverse that dysfunction. The American journal of cardiology. Nov 15 2004;94(10):1306-1310.

Singh A, Singh A, Sen D. Mesenchymal stem cells in cardiac regeneration: a detailed progress report of the last 6 years (2010–2015). Stem Cell Research & Therapy.2016;7:82.

Soja, A. M., and Mortensen, S. A. Treatment of congestive heart failure with coenzyme Q10 illuminated by meta-analyses of clinical trials. Mol. Aspects Med. 1997;18 Suppl:S159–68

Soukoulis, V., Dihu, J. B., Sole, M.,  Micronutrient deficiencies an unmet need in heart failure. J Am Coll Cardiol. 2009;54(18):1660–73

Stepura OB, Martynow AI. Magnesium orotate in severe congestive heart failure (MACH). International journal of cardiology. Jan 9 2009;131(2):293-295.

Stewart, R.E., Graham, D.M., Godfrey, G.W., Friedman, H.Z., Das, S.K., Shea, M.J. Rapidly progressive heart failure resulting from cardiac sarcoidosis. Am Heart J. 1988;115(6):1324-6

Stout, M., Tew, G. A., Doll, H., et al. Testosterone therapy during exercise rehabilitation in male patients with chronic heart failure who have low testosterone status: a double-blind randomized controlled feasibility study. Am. Heart J. 2012;164(6):893–901

Subramaniam S, Ramachandran S, Uthrapathi S, Gnamanickam VR, Dubey GP. Anti-hyperlipidemic and antioxidant potential of different fractions of Terminalia arjuna Roxb. bark against PX- 407 induced hyperlipidemia. Indian journal of experimental biology. Apr 2011;49(4):282-288.

Subramaniam S, Subramaniam R, Rajapandian S, Uthrapathi S, Gnanamanickam VR, Dubey GP. Anti-Atherogenic Activity of Ethanolic Fraction of Terminalia arjuna Bark on Hypercholesterolemic Rabbits. Evidence-based complementary and alternative medicine : eCAM. 2011;2011:487916.

Sultana N, Zhang L, Yan J, et al. Resident c-kit+ cells in the heart are not cardiac stem cells. Nature communications.2015;6.

Suskin, N., Sheth, T., Negassa, A., Yusuf, S. Relationship of current and past smoking to mortality and morbidity in patients with left ventricular dysfunction. J Am Coll Cardiol. 2001;37(6):1677-82

Szabó, T., Felger, D., Haehling, von, S., Lainscak, M., Anker, S. D., and Doehner, W. Overview of emerging pharmacotherapy in chronic heart failure. Expert Opin Pharmacother. 2009;10(13):2055–74

Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC), Steg, P. G., James, S. K. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. European Heart Journal. 2012;33(20):2569–619

Taylor AA, Siragy H, Nesbitt S. Angiotensin receptor blockers: pharmacology, efficacy, and safety. Journal of clinical hypertension (Greenwich, Conn.). Sep 2011;13(9):677-686.

TC JM, Seneviratne CK, Thabrew MI, Abeysekera AM. Antiradical and antilipoperoxidative effects of some plant extracts used by Sri Lankan traditional medical practitioners for cardioprotection. Phytotherapy research : PTR. Sep 2001;15(6):519-523.

Tejada, T., Fornoni, A., Lenz, O., Materson, B.J. Nonpharmacologic therapy for hypertension: does it really work?. Curr Cardiol Rep. 2006;8(6):418-24

Teva Pharmaceutical Industries. A Double-blind, Randomized, Sham-procedure-controlled, Parallel-group Efficacy and Safety Study of Allogenic Mesenchymal Precursor Cells (CEP-41750) in Patients With Chronic Heart Failure Due to Left Ventricular Systolic Dysfunction of Either Ischemic or Nonischemic Etiology. In: [Internet]. Bethesda (MD): National Library of Medicine (US). Last updated 2016 Aug 9. Available from NLM Identifier: NCT02032004.

Tirabassi G, Gioia A, Giovannini L, Boscaro M, Corona G, Carpi A, . . . Balercia G. Testosterone and cardiovascular risk. Internal and emergency medicine. Apr 2013;8 Suppl 1:S65-69.

Toma M, McAlister FA, Coglianese EE, Vidi V, Vasaiwala S, Bakal JA, . . . Ezekowitz JA. Testosterone supplementation in heart failure: a meta-analysis. Circulation. Heart failure. May 1 2012;5(3):315-321.

Tsutsui, T., Tsutamoto, T., Wada, A., Maeda, K., Mabuchi, N., Hayashi, M., et al. Plasma oxidized low-density lipoprotein as a prognostic predictor in patients with chronic congestive heart failure. J Am Coll Cardiol. 2002;39(6):957-62

Tyson, C. C., Nwankwo, C., Lin, P.-H., and Svetkey, L. P. The Dietary Approaches to Stop Hypertension (DASH) eating pattern in special populations. Curr. Hypertens. Rep. 2012;14(5):388–96

Urbonaviciute A, Jakstas V, Kornysova O, Janulis V, Maruska A. Capillary electrophoretic analysis of flavonoids in single-styled hawthorn (Crataegus monogyna Jacq.) ethanolic extracts. Journal of chromatography. A. Apr 21 2006;1112(1-2):339-344.

USSCC. US Stem Cell Clinic. Clinical Research page. Degenerative Conditions. Copyright 2016. Accessed 9/29/2016.

van Kimmenade, R. R. J., and Januzzi, J. L. Emerging biomarkers in heart failure. Clin Chem. 2012;58(1):127–38

Vestberg D, Rosengren A, Olsson M, Gudbjornsdottir S, Svensson AM, Lind M. Relationship Between Overweight and Obesity With Hospitalization for Heart Failure in 20,985 Patients With Type 1 Diabetes: A population-based study from the Swedish National Diabetes Registry. Diabetes care. Jun 11 2013.

Vijay, N., MacCarter, D., Shecterle, L. M., and St Cyr, J. A. D-ribose benefits heart failure patients. J Med Food. 2008;11(1):199–200

Volterrani, M., Rosano, G., and Iellamo, F. Testosterone and heart failure. Endocrine. 2012;42(2):272–7

Vrtovec B, Poglajen G, Haddad F. Stem cell therapy in patients with heart failure. Methodist DeBakey cardiovascular journal.Jan-Mar 2013;9(1):6-10.

Wang, M., Liao, Y. Value of quantitative analysis of serum cTnT in diagnosis of cardiac disease and myocardial injury. J Tongji Med Univ. 2000;20(1):53-4

Weber, M., Hamm, C. Role of B-type natriuretic peptide (BNP) and NT-proBNP in clinical routine. Heart. 2006;92(6):843-9

Weintraub, N. L., Collins, S. P., Pang, P. S.,  Acute heart failure syndromes: emergency department presentation, treatment, and disposition: current approaches and future aims: a scientific statement from the American Heart Association. Circulation. 2010;122(19):1975–96

Westenbrink BD, Visser FW, Voors AA, Smilde TD, Lipsic E, Navis G, . . . van Veldhuisen DJ. Anaemia in chronic heart failure is not only related to impaired renal perfusion and blunted erythropoietin production, but to fluid retention as well. European heart journal. Jan 2007;28(2):166-171.

Whooley, M.A. Depression and cardiovascular disease: healing the broken-hearted. JAMA. 2006;295(24):2874-81

Witham, M. D., Crighton, L. J., Gillespie, N. D., Struthers, A. D., and McMurdo, M. E. T. The effects of vitamin D supplementation on physical function and quality of life in older patients with heart failure: a randomized controlled trial. Circ Heart Fail. 2010;3(2):195–201

Witham, M. D., Nadir, M. A., and Struthers, A. D. Effect of vitamin D on blood pressure: a systematic review and meta-analysis. J. Hypertens. 2009;27(10):1948–54

Wong PC, Guo J, Zhang A. The renal and cardiovascular effects of natriuretic peptides. Advances in physiology education. Jun 01 2017;41(2):179-185.

Xin, W., Wei, W., and Li, X. Effects of fish oil supplementation on cardiac function in chronic heart failure: a meta-analysis of randomised controlled trials. Heart. 2012;98(22):1620–5

Xu, F., Mack, C. P., Quandt, K. S., Shlafer, M., Massey, V., and Hultquist, D. E. Pyrroloquinoline quinone acts with flavin reductase to reduce ferryl myoglobin in vitro and protects isolated heart from re-oxygenation injury. Biochem Biophys Res Commun. 1993;193(1):434–9

Yaggi HK, Concato J. Obstructive Sleep Apnea as a Risk Factor for Stroke and Death. NEJM. 2005;353(19):2034-41.

Yancy, C.W., Jessup, M., Bozkurt, B., and the ACCF/AHA Task Force Members. 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013;PubMed PMID: 23747642

Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE, Jr., Colvin MM, . . . Westlake C. 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. J Card Fail. Aug 2017;23(8):628-651.

Yandrapalli S, Aronow WS, Mondal P, Chabbott DR. The evolution of natriuretic peptide augmentation in management of heart failure and the role of sacubitril/valsartan. Archives of medical science : AMS. Aug 2017;13(5):1207-1216.

Yang B, Liu P. Composition and health effects of phenolic compounds in hawthorn (Crataegus spp.) of different origins. Journal of the science of food and agriculture. Jun 2012;92(8):1578-1590.

Zhang L, Lu Y, Jiang H, Zhang L, Sun A, Zou Y, Ge J. Additional use of trimetazidine in patients with chronic heart failure: a meta-analysis. Journal of the American College of Cardiology. Mar 6 2012;59(10):913-922.

Zhu, B.-Q., Simonis, U., Cecchini, G., et al. Comparison of pyrroloquinoline quinone and/or metoprolol on myocardial infarct size and mitochondrial damage in a rat model of ischemia/reperfusion injury. J. Cardiovasc. Pharmacol. Ther. 2006;11(2):119–28

Zhu, B.-Q., Zhou, H.-Z., Teerlink, J. R., and Karliner, J. S. Pyrroloquinoline quinone (PQQ) decreases myocardial infarct size and improves cardiac function in rat models of ischemia and ischemia/reperfusion. Cardiovasc Drugs Ther. 2004;18(6):421–31

Zick, S. M., Vautaw, B. M., Gillespie, B., and Aaronson, K. D. Hawthorn Extract Randomized Blinded Chronic Heart Failure (HERB CHF) trial. Eur. J. Heart Fail. 2009;11(10):990–9.